Two non-public stock offerings

As part of our cooperation with Biogened S.A., we advised on the organization of a private placement of shares, as part of which the Company attracted institutional investors, including a specialized fund investing in the medical sector and one of the pension funds. The total amount raised by Biogened S.A. in the offering was PLN 3 million.

Biogened S.A. is a NewConnect-listed manufacturer of generic drugs, dermo cosmetics, and dietary supplements with 70 years of experience. The company has its own manufacturing and laboratory facilities to produce generic drugs and develop its own OTC product lines. The Company has developed the DERMEDIC brand, which has been creating scientifically advanced skin care solutions for all skin types for more than a dozen years. In developing product formulations, the Company uses the latest trends in dermatology and global technologies. Growing confidence among consumers in the dermo cosmetics product range has resulted in the brand being awarded numerous prizes and distinctions. In 2017, Biogened S.A. received the prestigious Good Manufacturing Practice (GMP) certificate, which confirms the implementation and maintenance of a quality system that meets the requirements of EN ISO 22716:2007 Cosmetics – Good Manufacturing Practices (GMP).

Service: Raising capital and investors

Client:

BIOGENED S.A.